Cite
APA Citation
Gilboa, M., Mandelboim, M., Indenbaum, V., Lustig, Y., Cohen, C., Rahav, G., Asraf, K., Amit, S., Jaber, H., Nemet, I., Kliker, L., Bar-Haim, E., Mendelson, E., Doolman, R., Rubin, C., Regev-Yochay, G., & Kreiss, Y. (2022). early Immunogenicity and Safety of the Third Dose of BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine Among Adults Older Than 60 Years: Real-World Experience. Journal of infectious diseases, 225, 785–792. http://access.bl.uk/ark:/81055/vdc_100151266693.0x00003f